Introduction {#sec0005}
============

Drugs policy over the last two decades in the UK, and other countries, such as the US and Australia, has been very strongly influenced by the assumed link between drugs and crime ([@bib0175], [@bib0185], [@bib0190]) and the idea that tackling drug use will affect crime. Existing evidence suggests a strong link between illicit drug use and involvement in crime ([@bib0050]), especially income-generating, acquisitive crime ([@bib0080]). The association has been observed primarily among arrestees ([@bib0350]), prisoners ([@bib0215]) and people entering drug treatment ([@bib0110]). However, these groups may not be representative of the wider drug-using population as offending rates can be atypical in the period immediately prior to arrest, imprisonment or treatment ([@bib0260]); and drug-using offenders may be more likely than non-using offenders to be apprehended ([@bib0060]).

The drug-crime link appears particularly compelling among individuals with frequent and problematic use of opiates, such as heroin ([@bib0225]), and/or crack cocaine ([@bib0050], [@bib0095]). Evidence synthesis concludes that the odds of offending are six times greater for crack users than non-crack users and three times greater for heroin users than non-heroin users ([@bib0050]). Opiate/crack users comprise 81% of those in receipt of structured drug treatment services in England and are the group predominantly targeted by policy initiatives to divert drug-using offenders into treatment ([@bib0185], [@bib0340]). For these reasons, our review focuses on opiate/crack users.

The drug-crime association is supported by studies indicating the impact of periods of addiction versus non-addiction on offending ([@bib0295]). Receipt of drug treatment is associated with reduced offending ([@bib0075]) and higher offending rates are associated with more serious drug use ([@bib0160]).

Studies examining gender differences in the opiate use--crime relationship, in particular, tend to agree that males: are younger at crime onset ([@bib0125]), commit a higher volume of crime ([@bib0155]) and initiate opiate use at a younger age than females ([@bib0125]). However, while females appear more likely to proceed from opiate-use onset to crime ([@bib0395]), crime tends to precede opiate use for males ([@bib0225]). Some studies point to a higher likelihood of offending in female drug users than in male drug users ([@bib0050], [@bib0350]).

There is continued debate about whether the existing evidence is sufficiently robust to indicate a causal relationship between drug use and crime ([@bib0365]), although much of UK drug policy is explicitly grounded in the existence of a causal link ([@bib0175], [@bib0185], [@bib0190]). One theory for the associative pathway between opiate use and crime is the need to generate income to fund expensive drug use ([@bib0050], [@bib0140]). However, [@bib0165] have demonstrated elsewhere that behavioural and demographic factors are associated more strongly with acquisitive crime than drug use expenditure. Further, although a small proportion of opiate-using offenders commit a high volume of crime ([@bib0080]) some commit no crime ([@bib0290]). Other theories imply that the pathway reflects that illegality of drug use promotes opportunities for further involvement with criminal networks ([@bib0160]). A further theory proposes that the pathway results from the psychopharmacological effects of drug use on behaviour. For example, ingestion of stimulant psychoactive substances, such as crack cocaine, has been linked to violent criminal behaviour ([@bib0070]). Furthermore, the observed association itself may be spurious ([@bib0010]), i.e. due to a third extraneous factor, or common cause, separately implicated in both opiate/crack use and offending, for example, socioeconomic factors ([@bib0135]) or personality disorder ([@bib0380]).

The establishment of a causal relationship between drug use and crime requires evidence of temporal order in addition to evidence of an association. The observed association between the putative independent variable (drug use) and the dependent variable (crime) does not necessarily imply causation ([@bib0010]). The establishment of causation requires evidence that the cause (drug use) precedes the effect (crime) in the pathway. The existing evidence appears limited in its capacity to establish temporal order in the drug use--crime relationship; i.e. is opiate/crack-use onset more likely to precede offending or vice versa? Existing evidence is inconsistent in its choice of crime categories: some studies do not differentiate crime by type (e.g. [@bib0385]). Others group dissimilar drugs when examining the impact of drug use on crime and/or include alcohol in measures of substance misuse (e.g. [@bib0240]). Existing literature is limited in its coverage of the pre-addiction period, despite recommendations from almost 40 years ago that research should focus on "criminal behaviour prior to the onset of use" ([@bib0360]).

Evidence synthesis of studies focusing specifically on pathways through drug use and offending is absent. Much of the review literature concentrates on the effectiveness of criminal justice responses to existing offending by drug users ([@bib0170], [@bib0325], [@bib0330]) or focuses on the strength of the relationship between existing drug use and crime ([@bib0050]).

We set out to clarify the strength of the evidence in this area and whether, and to what extent, available evidence reflects current patterns of behaviour and supports current policy responses. We conducted a systematic review with three main aims: (1) to explore the temporal order between opiate/crack use and crime initiation in studies examining the pathway through opiate/crack use and offending; (2) to examine the impact of opiate/crack-use onset on crime rates; and (3) to examine factors that might influence the relationship between opiate/crack-use onset and crime, for example, gender.

Methods {#sec0010}
=======

Systematic review methods were based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement ([@bib0265]).

Study identification {#sec0015}
--------------------

Relevant studies were identified via electronic databases, online sources and bibliography screening. Comprehensive search terms, comprising medical subject headings, thesaurus terms and text words derived from titles and keywords of published literature, were developed using the Applied Social Sciences Index and Abstracts (ASSIA) database. The full search strategy is available online ([Supplementary Table 1](#sec0135){ref-type="sec"}). The search string was applied to the following databases: ASSIA; Social Services Abstracts; Sociological Abstracts; International Bibliography of the Social Sciences (IBSS); and National Criminal Justice Reference Service (NCJRS) with databases searched since inception. Supplementary searches were performed on PubMed, DrugScope and UK Home Office online resources. Bibliographies of retrieved manuscripts were screened and citation mapping (ISI Web of Science) identified further publications cited by included studies. Searches were completed in June 2014. No setting, date or geographical restrictions were applied; searches were limited to English language sources.

Inclusion and eligibility {#sec0020}
-------------------------

Included studies met the following criteria: focus on use of opiates and/or crack cocaine (the population of interest); focus on criminal offending (the behaviour of interest); pre-opiate/crack-use initiation information (necessary to establish temporal order); findings from longitudinal studies with corroborative official crime records (necessary to establish developmental causality in offending and avoid recall bias); and findings from primary data collection or systematic review. Non-peer-reviewed findings reported solely in books, conference proceedings, dissertations or theses were excluded. The inclusion criteria were applied to titles and abstracts of retrieved studies; the full text of those potentially relevant was screened independently by two reviewers, with 100 per cent agreement following discussion, although a third reviewer was available to resolve disagreements. Risk of bias was assessed by the Newcastle-Ottawa quality assessment scale for cohort studies ([@bib0435]). This scale is recommended for quality assessment in epidemiological systematic reviews ([@bib0115]) and is regularly used in systematic reviews of observational health studies (e.g. [@bib0035]). Content/face validity and inter-rater reliability have been established. The Newcastle--Ottawa scale comprises eight items covering appropriateness of selection criteria used (maximum score 4), comparability of participant groups (maximum score 2) and assessment of outcome (maximum score 3); a higher score (out of a possible 9) indicates lower risk of bias ([@bib0115]).

Data synthesis {#sec0025}
--------------

Data were extracted from included studies via a piloted data extraction form and verified by a second reviewer. The following data were extracted: study characteristics ([Table 1](#tbl0005){ref-type="table"}, [Table 2](#tbl0010){ref-type="table"}); average age at opiate/crack onset; average age at (recorded) offending onset ([Table 3](#tbl0015){ref-type="table"}); and offending rates ([Table 4](#tbl0020){ref-type="table"}, [Table 5](#tbl0025){ref-type="table"}). Offending rates were grouped according to offence type. Rate ratios (RR) of post-use initiation to pre-use initiation were calculated. The log of the RR was pooled via meta-analysis using random effects models. Meta-analysis is the statistical synthesis of results from a series of studies; random effects are chosen where variation among studies is expected ([@bib0065]). Heterogeneity was assessed using Chi^2^ and I^2^ statistics. Funnel plots were interpreted visually to assess the extent of possible publication bias. Meta-analysis was carried out via Review Manager (version 5.3).

Results {#sec0030}
=======

Searches resulted in 5204 hits: ASSIA (1530); Social Services Abstracts (879); Sociological Abstracts (1601); IBSS (389); and NCJRS (321). Supplementary searches resulted in additional hits: PubMed (114); DrugScope (81); UK Home Office (5); bibliography search (190); and citation mapping (94).

Screening of titles and abstracts excluded the majority, with 227 manuscripts proceeding to an examination of the full text. Most (*n* = 123, 54%) were excluded due to a lack of focus on opiates and/or crack use (see [Fig. 1](#fig0005){ref-type="fig"}).

Six US studies ([@bib0020], [@bib0030], [@bib0015], [@bib0025], [@bib0120], [@bib0195]) identified by the search process utilised the same three samples of patients. We used data from one of these set of six studies ([@bib0030]) in our review. One included paper ([@bib0270]) provided a summary of studies reported elsewhere in greater detail ([@bib0275], [@bib0280]) in addition to a summary of a third additional sample.

Description of included studies {#sec0035}
-------------------------------

Twenty studies were included (see [Table 1](#tbl0005){ref-type="table"}, [Table 2](#tbl0010){ref-type="table"}), nine from the UK and 11 from the US. Research settings included drug treatment clinics (6), hospital (5), community (3), prison (3), not reported (1) and combined (2: hospital/general practice and prison/drug dependency clinic).

All studies focused on pathways through opiate use and crime. Nine studies with a focus on crack cocaine were excluded at the screening stage (no offending focus: 4; no longitudinal data: 4; no primary data: 1). Mean duration of addiction was reported by only four studies (range 12.9 months--16.8 yrs). The earliest data were collected on admission to a US hospital between 1935 and 1959 ([@bib0300]); the most recent in 1987 ([@bib0210]).

Ten studies (50%) reported data from over 200 clients (range 34: [@bib0040] to 765: [@bib0420], median 205, IQR 89--272). Studies were all male (6), all female (2), gender not reported (2) or mixed (10) with an average 70% (SD 15%) male. Ten studies reported mean age (29 yrs, range 20--37 yrs, 95% CI 25--32). Nine studies did not report ethnicity; elsewhere ethnic group was White, Black, Mexican American, Hispanic and Native American. Five studies ([@bib0145], [@bib0205], [@bib0275], [@bib0315], [@bib0105]) reported use of a comparison group. Quality scores ranged from 3 to 7, out of a possible 9. Studies reporting offending rates, with the potential for pooling, had quality scores ranging from 5 to 7 (out of 9). Lower quality studies (scoring a total of 3 or 4) were characterised by inadequate details of follow-up and by a failure to control for the length of observation periods ([@bib0040], [@bib0270], [@bib0420]).

Findings of included studies {#sec0040}
----------------------------

### Age at opiate-use onset {#sec0045}

Five studies report mean age at self-reported first opioid use ([Table 3](#tbl0015){ref-type="table"}: range 16.6 yrs: [@bib0275] to 27.4 yrs: [@bib0090]; mean 19.6 yrs, 95% CI 17.4--21.8).

### Age at offending onset {#sec0050}

Five studies report mean age at (recorded) offending onset ([Table 3](#tbl0015){ref-type="table"}: range 13.7 yrs: [@bib0205] to 22.4 yrs: [@bib0090]; mean 16.7 yrs, 95% CI 14.3--19.0). The CI (13.8--19.4) was widened by removal of one study ([@bib0200]) which reported mean age at first conviction rather than first arrest.

Temporal order of opiate use and offending {#sec0055}
------------------------------------------

[Table 3](#tbl0015){ref-type="table"}, [Table 4](#tbl0020){ref-type="table"}, [Table 5](#tbl0025){ref-type="table"} and [Fig. 2](#fig0010){ref-type="fig"} indicate that the mean age at (recorded) offending onset (16.7 yrs, 95% CI 14.3--19.0) precedes the mean age at opiate-use onset (19.6 yrs, 95% CI 17.4--21.8) by 2.9 yrs. Four studies ([@bib0030], [@bib0090], [@bib0205], [@bib0260]) explicitly report mean age at opiate-use onset and at offending onset in the same sample ([Table 3](#tbl0015){ref-type="table"}); however, all four fail to report the standard deviation for within-person delay from offending to opiate-use onset so therefore these estimates cannot be accurately pooled. Mean age at (recorded) offending onset preceded mean age at opiate-use onset in these four studies with the difference in means ranging from 2.6 yrs ([@bib0090]) to 5.2 yrs ([@bib0205]).

Type and volume of offending {#sec0060}
----------------------------

Nine studies reported neither offending rates nor duration of observation periods and number of arrests/convictions to allow rate calculation. Ten (50%) reported offending rates ([@bib0005], [@bib0030], [@bib0105], [@bib0210][@bib0260], [@bib0285], [@bib0315], [@bib0425], 1976; [@bib0440]). Rates of serious crime increased after addiction onset in [@bib0285] but rates were presented in bands (e.g. 0.5--0.99) and could not be synthesised. [@bib0280] did not present offending rates but reported number of convictions (males only) and median duration of each stage, enabling calculation of an approximate rate. Offence rates for the 10 studies with useable data are presented in [Table 4](#tbl0020){ref-type="table"}, [Table 5](#tbl0025){ref-type="table"}.

Data on the influence of onset-opiate use on total rates of offending ([Table 4](#tbl0020){ref-type="table"}) were combined in a meta-analysis ([Fig. 2](#fig0010){ref-type="fig"}), using a random effects model. Substantial heterogeneity (Chi^2^ = 689.9, df 14, *p* \< 0.001, *I*^2^ = 98%) meant that it was uninformative to produce an overall rate ratio (RR). Using the vote method to synthesise data, RRs (comparing post-opiate use with pre-opiate use) ranged from 0.71 (95% CI 0.40--1.3: [@bib0005]) to 25.7 (95% CI 8.9--74.0: [@bib0430]) across 27 subsamples from 10 studies. A positive association, i.e. higher rate post opiate onset, versus pre opiate onset, was observed in 22 of 27 subsamples. A negative association was seen in one subsample ([@bib0425]) and four subsamples in two further studies reported equivocal associations, where CIs cross one ([@bib0005], [@bib0425]) ([Table 4](#tbl0020){ref-type="table"}). For the pooled data, 14 out of 15 independent samples had a positive association. We tested whether this was due to random error using the sign-test. The resulting *p* value was 0.001, demonstrating that this finding was unlikely to be due to chance.

[Table 5](#tbl0025){ref-type="table"} shows recorded offending rates for crime categories. RRs for theft, burglary and violence were derived from 7 studies; RRs for robbery from 5 studies. RRs for theft ranged from 0.63 (95% CI 0.38--1.0: [@bib0425]) to 8.3 (95% CI 6.6--10.5: [@bib0105]) with a positive association in 13 subsamples, an equivocal association in nine and a negative association in one. For burglary, RRs ranged from 0.74 (95% CI 0.45--1.2: [@bib0425]) to 50.0 (95% CI 0.02--110727.0: [@bib0430]) with positive associations in nine subsamples and equivocal associations in 13 (one subsample had a zero pre opiate onset rate). RRs for violence ranged from 0.39 (95% CI 0.11--1.4: [@bib0425]) to 16.0 (95% CI 3.3--77.4: [@bib0425]) with positive associations in six subsamples and equivocal associations in 15 (two subsamples had zero pre opiate onset rates). For robbery, RRs ranged from 0.50 (95% CI 0.18--1.4: [@bib0260]) to 5.0 (95% CI 1.6--15.8: [@bib0260]); only five subsamples had positive associations, 15 equivocal associations and one subsample had a zero pre opiate onset rate.

Drug offence rates were not pooled due to the expectation that these would increase post-opiate use onset. Two studies reported data on forgery ([@bib0030], [@bib0260]); both finding an increase post opiate onset but from zero pre opiate onset rates in one study. Rates of sexual assault were reported in three studies ([@bib0105], [@bib0280], [@bib0430]); one had zero rates ([@bib0430]) and two were unable to detect a reliable change ([@bib0105], [@bib0280]). Rates of prostitution were reported in three studies ([@bib0105], [@bib0425]; 1976) two with all-female subsamples (see [Table 1](#tbl0005){ref-type="table"}, [Table 5](#tbl0025){ref-type="table"}). Rates decreased in one group (RR 0.69, CI 0.35--1.3) and increased in the other from a previously zero rate.

[Table 5](#tbl0025){ref-type="table"} suggests offending rates increase post-opiate use onset across the crime categories of theft and burglary ([Supplementary Figs. 2 and 3](#sec0135){ref-type="sec"}). Funnel plots of effect estimate (RR) against standard error (log RR) show potential publication bias with a lack of non-significant findings from studies with small sample sizes.

Meta-regression was used to examine potential sources of between-study heterogeneity including: sample size, study quality score, country, setting, study date and gender; 95% CIs for adjusted RRs all crossed one with no significant predictors of the Rate Ratio.

Studies comparing offending with a non-drug-using population {#sec0065}
------------------------------------------------------------

Although not an inclusion criterion, those studies which attempted to set offending details against a comparison group were examined further. [@bib0105] compared arrest rates for an addict group (*n* = 210) with the general population in the study location (*n* = 191,000). Property crime arrest rates were comparable pre opiate onset (0.9 vs. 0.7) but higher post opiate onset in the addict group (8.9 vs. 0.7). However, comparison group data were derived from arrest rates divided by the total population and age was not accounted for. [@bib0315] used a comparison group (*n* = 188) of non-drug-using offenders. User offenders' acquisitive crime rates increased substantially (0.3--1.2) compared to non-drug-using offenders (0.2--0.7). However, analysis assumed the timing of opiate-use onset based on that of a local heroin epidemic ([@bib0310]) and did not adjust for age, although the groups' age distributions were similar (17--32 yrs). [@bib0205] compared an opiate-using addict group (*n* = 68) with a non-addict offender group (*n* = 64). Self-reported mean age of first criminal involvement was lower for addicts (13.0 vs. 14.2 yrs) although the standard error for the difference in means was not reported. As adults, addicts were more likely to commit forgery (21% vs. 8%) although no details are provided on pre-opiate use offence volume and type. [@bib0145] analysed findings according to heroin vs. other drug use. Pre-opiate onset conviction levels were similar; the incidence of larceny increased post-opiate onset (37--80%) for the heroin user group but not the group using other drugs. However, offence rates and details of observation periods were not presented.

Potential interactions between opiate use and offending {#sec0070}
-------------------------------------------------------

Review findings were used to examine how epoch, gender, volume and type of pre opiate onset offending and age at opiate use onset might impact upon the opiate use--crime relationship. Ethnicity was not included due to differences between countries and epochs and the confounding effects of socio-economic factors ([@bib0130], [@bib0245]).

Four studies \>([@bib0105], [@bib0260], [@bib0285], [@bib0300]) suggest later cohorts have higher arrest rates both pre- and post-opiate use onset. [@bib0105] suggested that increases in the extent of the relationship between opiate use and offending over time (start of daily use plotted against arrest frequency in the same jurisdiction) result from an increase in the price of heroin and increased law enforcement efforts.

Where reported, studies suggest a gender impact on the opiate use--crime relationship with greater escalation and a somewhat different pattern of offending in females. Substantial increases occur post-opiate use onset for females (e.g. pre-addiction larceny rate of 0.15 for males vs. 0.05 for females, increasing to 0.35 post-addiction in both: [@bib0430]). Increases were also more likely for burglary (50-fold increase with a wide CI from 0.002 to 0.10, 95% CI 0.02--110727.0 in females, compared to a 2-fold increase from 0.11 to 0.23 in males: [@bib0430]) and assault (16-fold increase from 0.03 to 0.50 (95% CI 3.4--82.5) in females compared to a small increase from 0.10 to 0.11 in males: [@bib0425]). [@bib0440] report that conviction rates did not differ significantly by gender.

Disaggregating by crime type, studies suggest participation in acquisitive crime pre- and post-opiate use onset, with post-onset escalation mainly limited to acquisitive crime ([@bib0210], [@bib0315]). Minor acquisitive crime, e.g. theft, appears more likely to precede addiction ([@bib0030]). The proportion involved in property crime increases post-opiate use onset ([@bib0425], 1976; [@bib0440]), e.g. from below 50% to over 80% in [@bib0030]. A number of studies suggest no significant impact of opiate-use onset on violent offending ([@bib0005], [@bib0280], [@bib0420]) while others do ([@bib0275], [@bib0300]).

Findings from studies that group individuals on the basis of age at opiate-use onset ([@bib0300], [@bib0420], [@bib0425], 1976) suggest this affects the opiate use--crime relationship; large increases in offending post-opiate onset are observed in early-onset cases with a history of arrests prior to drug use (two studies recruit at prison entry: [@bib0425], 1976). The youngest opiate use onset group is characterised by increases in assault (2-fold increase from 0.10 to 0.19: 13--20 onset: [@bib0425]) and larceny (7-fold increase from 0.05 to 0.35: 13--17 onset: [@bib0430]), whereas later opiate use onset groups had greater increases for burglary and robbery (5-fold increase for burglary from 0.12 to 0.59: 21--25 onset: [@bib0425]).

Other findings {#sec0075}
--------------

The impact of money spent on drugs on crime participation was highlighted ([@bib0030], [@bib0105], [@bib0145]), although participants were described as unable to provide reliable estimates of drug expenditure ([@bib0205]). Similarly, income derived from crime was reported ([@bib0205], [@bib0260]) although one study cautioned that participants did not consider the value of goods stolen for personal use rather than resale as illegal income, leading to substantial underestimation ([@bib0205]).

Studies commented on the intervening role played by (undetected) drug dealing in determining the extent of the drugs-crime relationship ([@bib0030], [@bib0205]). Over 50% of participants' time was taken up by dealing drugs ([@bib0260]), which could contribute two-thirds of addicts' income ([@bib0205]). Self-report confirms an increase in acquisitive crime; 65% of heroin users (*n* = 46) in one study reported supporting their drug use via acquisitive crime ([@bib0210]). A further study recorded participants' perceptions of addiction onset on crime; 84% reported no change in assault, whereas 46% reported a substantial increase in theft ([@bib0430]).

Discussion {#sec0080}
==========

The literature on pathways through opiate/crack use and offending was systematically reviewed. This appears to be the first systematic review to concentrate specifically on such pathways. Twenty studies (11 US, 9 UK) were included from over 5000 hits. Most took place in drug treatment clinics and all focused on opiate use.

Summary of main findings {#sec0085}
------------------------

Mean age at opiate-use onset was 19.6 yrs and mean age at offending onset (usually arrest) was 16.7 yrs, pointing to evidence supporting the pathway whereby offending precedes opiate use initiation in studies setting out sufficient data on the temporal sequence of opiate use and offending. Individual studies suggest increases in rates of acquisitive crime, such as theft ([@bib0210]), burglary ([@bib0300]), and robbery ([@bib0430]) following opiate-use onset. Substantial between-study heterogeneity (above 80%), not explained by meta-regression, meant that rate ratios should not be pooled via meta-analysis. Studies reporting crime rates suggest that these increase following opiate-use onset: positive association in 22 subsamples, equivocal association in four subsamples and a negative association in one subsample (RR range 0.71--25.7). The majority of independent samples (14/15) had a positive association; this finding is unlikely to be due to chance, according to a sign test (*p* = 0.001). For individual crime categories, the strongest evidence was available for theft (positive association in 13 subsamples, equivocal association in 9 subsamples and a negative association in one: RR 0.63--8.3). Gender and age at opiate-use onset appear to moderate the strength of the opiate use--crime relationship. Opiate-use onset escalates already-existing criminal behaviour, particularly for acquisitive crime types, although the available evidence is highly heterogeneous and not up to date.

Limitations {#sec0090}
-----------

None of the included studies reported on the use of crack cocaine; findings therefore relate to pathways through opiate use and crime. In England, opiate users account for 79% of the drug treatment population, meaning that findings have relevance to the UK situation ([@bib0340]). Although heroin use would appear to be declining in the UK, given low rates of use among young people in available indicator data (2013/14 NDTMS data), there remains an older population of heroin users who are targeted for intervention on the premise that their drug use causes crime. The focus on opiate use is also important given recent concern over increasing mortality rates associated with opiate use in both the UK ([@bib0345]) and other countries, such as Australia ([@bib0230]) and the US ([@bib0220]). Available evidence does point to divergent patterns of problematic drug use between countries. For example, methamphetamine use is expanding across South East Asia ([@bib0410]) and is the focus of interventions to target drug-related crime in the US ([@bib0170]), potentially limiting the generalisability of review findings. The recent increase in heroin use in the US ([@bib0085], [@bib0220]), however, does indicate the potential for further work on the nuances of the opiate-crime relationship in a contemporary population.

The absence of studies focusing on crack cocaine in the review highlights that much of the available evidence base in this area predates the widespread prevalence of crack cocaine use. In addition, particularly in the UK, crack is a substance that opiate users have added to their drug-taking repertoire, meaning that crack use in the absence of opiate use is relatively uncommon in the UK ([@bib0340]).

None of the studies compared crime rates between opiate users and non-drug-users to establish whether opiate-use onset is associated with surplus crime, while controlling for confounding factors, such as age or incarceration. In essence, included studies use a mirror-image design of before/after opiate-use onset in the same person. Most research in this field does not control for age-confounding: there is typically a steep rise in offending through adolescence ([@bib0400]), the typical period for opiate-use onset ([@bib0250]). Thus, without a comparison group, it is not possible to ascribe opiate-use onset as the cause of increased offending. A few studies attempted to set offending details against a comparison group but these were characterised by design flaws, such as not controlling for age ([@bib0105], [@bib0315]), providing insufficient details on pre-opiate use offending ([@bib0205]) and not taking account of differential observation periods ([@bib0145]).

All studies originated from the UK and US, despite a comprehensive literature search. The available evidence base may be biased due to the absence of published studies with non-significant results ([@bib0415]); the funnel plot pointed to this possibility. Eligibility was restricted to peer-reviewed evidence to ensure a degree of robustness; previous work points to often important differences between, for example, conference abstracts and peer-reviewed manuscripts reporting the same study ([@bib0405]). Only two studies used baseline data collected after 1980 ([@bib0210], [@bib0315]) and are, therefore, better able to inform the UK situation subsequent to the heroin 'epidemics' of the early-1980s ([@bib0320]). The lack of contemporary research in the available literature suggests that researchers consider that the opiate use--crime relationship is completely determined. However, this review highlights that data essential to establishing the temporal nature of the relationship have not previously been synthesised. In addition, the review highlights the dearth of studies covering the period prior to drug-use initiation and the lack of high-quality research, employing a non-drug-using comparison group, needed to comprehensively implicate onset-opiate use in the acceleration of existing offending behaviour.

Differences in epoch are a conspicuous limitation in extrapolating review findings to current opiate-using offenders. Earlier cohorts may differ in critical respects: they are more likely to (1) have become addicted (and sustained their addiction) via prescribed treatment ([@bib0090]); (2) be older at addiction onset ([@bib0300]); and (3) engage in behaviour indicative of deviant rather than criminal tendencies ([@bib0040], [@bib0300]). Difficulties also arise when accounting for findings from UK studies ([@bib0040], [@bib0440]) undertaken when heroin was available on prescription. This highlights that the drugs-crime link will vary across both time and geography ([@bib0365]); given that it is not an invariant relationship, but is shaped by the wider context, a review drawing on studies from diverse locations and time periods will, understandably, be characterised by between-study heterogeneity. However, heterogeneity may have been exaggerated by post hoc selective sub-grouping of study participants.

We agree with others that large longitudinal datasets are necessary to investigate developmental causality in offending ([@bib0055]). We therefore focused on longitudinal data with corroborative official crime records. Much of the existing literature derives from cross-sectional studies of self-report data (e.g., [@bib0235], [@bib0395]), the accuracy of which will be tempered by recall bias, particularly over long time periods ([@bib0100]). However, recorded crime underestimates levels of criminal activity; there will be a lag between first crime and first arrest and between first arrest and first conviction. Self-reported mean age at first crime precedes age at first juvenile arrest by 1.4 yrs in one included study ([@bib0205]). It is tenable that studies suggesting that drug use precedes crime include participants whose offending went undetected prior to drug use, indicating the need for self-report data to supplement information on recorded sanctioned offending.

Not all studies explicitly supplied information about offending rates. Even where rates were provided, studies with shorter post-opiate use onset follow-up will have higher RRs due to the relationship between age and crime; analyses stratified by age at cohort entry, e.g. pre-specified 5-year age epochs (15--19, 20--24, etc.) are more appropriate. As a minimum, studies in this field would have greater value if the following were consistently reported: Criminal Justice System (CJS) events pre-opiate use onset; person-years (PYs) pre-opiate use onset; mean age at opiate use onset with standard deviation (sd); CJS events post-opiate use onset; PYs post-opiate use onset; and mean years of follow-up (sd) post-opiate use onset. For before/after studies, the SD for within-client delay from CJS-onset to opiate use onset is required in order to accurately pool estimates.

Meta-analysis was used to pool rate ratios (RR) of post-drug use initiation to pre-drug use initiation. An issue with this measure is that the available data were paired, i.e. the comparison between pre-opiate use and post-opiate use onset was undertaken on the same individual; subject-specific effects will mean that the two periods will be highly correlated. All included studies surveyed failed to account for these effects, therefore the estimates will be overly precise. Similarly, a number of subsamples were derived from two studies by Weissman ([@bib0425], 1976) leading to the potential for unobserved heterogeneity. Insufficient data were available to examine the impact of socioeconomic status on between-study heterogeneity; this factor has been linked to both crime and drug use ([@bib0135]). Substantial levels of between-study heterogeneity meant that data were unable to be pooled and were presented using the vote method. The vote method is limited as non-significant findings may be due to a lack of statistical power rather than the absence of an effect ([@bib0065], [@bib0150]).

Implications and findings in relation to other evidence {#sec0095}
-------------------------------------------------------

### Temporal order of opiate use and offending {#sec0100}

The mean age of recorded offending preceded the mean age at opiate-use onset by 2.9 yrs. This can be compared with UK norms reported by [@bib0355] comprising survey data on 12--30 yr olds. Mean age of onset for minor crime (14.5 yrs) in the Pudney sample preceded mean age at opiate-use onset by 3 years for heroin and 3.9 years for crack cocaine. In the studies reviewed here, offending onset preceded opiate-use onset, with rates of total offending increasing post-opiate use. Notwithstanding the limitations imposed by design flaws in the included studies, the implication is that opiate-use onset escalates already-existing criminal behaviour.

### Type and volume of offending {#sec0105}

Drugs offences were not synthesised as increased rates were expected post-opiate use onset. RRs for other offence types suggest that offending increases post-opiate use, particularly for theft and possibly burglary. As concluded by one of the studies, opiate users focus on those offence types which provide a satisfactory return, are within the skill set of the individual and carry the lowest risk of arrest ([@bib0205]).

Findings for violent offending were less certain. Previous work suggests no relationship between heroin onset and onset or escalation of violent crime ([@bib0305]). The association of non-opiate drugs, such as crack cocaine, with violent crime may be due to usage in combination with alcohol ([@bib0255]). However, others have highlighted alcohol\'s facilitative role in acts of crime by heroin users ([@bib0390]) suggesting that the role of alcohol in the drugs-crime link requires further investigation.

Similarly, opiate users are often poly-drug users, limiting capacity to ascribe causality specifically to opiates. For example, the opiate-using sample in one study reviewed here ([@bib0145]) also used amphetamines, a drug associated with both violent ([@bib0445]) and non-violent crime ([@bib0235]). In terms of contemporary samples, 40% of opiate users treated during 2012/13 in England also used crack ([@bib0335]). Others have highlighted that the number of drug types used correlates with offending rates ([@bib0045]) and that heroin users, for example, commit different types of crime according to their non-opiate adjunctive drug use ([@bib0370]). Further robust research on the nature of offending in poly-drug users is required.

### Interactions with opiate use and offending {#sec0110}

Females have lower offence rates pre-opiate use than males, confirming previous findings ([@bib0155]) but a greater escalation of criminal behaviour post-opiate use. As females' post-opiate use crime rates escalate from lower levels, higher RRs result. Others have argued that female opiate using offenders develop more serious drug dependence than their male counterparts ([@bib0180]). Large increases in post-opiate use crime are observed in early-onset opiate use preceded by delinquency and crime, although in the absence of a control group it is impossible to rule out an age effect operating here and it is not known whether sub-grouping by age at opiate use onset took place post hoc.

Differences may exist between opiate user and non-opiate user samples prior to opiate-use onset, thus research in this field should employ a matched non-opiate user comparison group. For example, it is suggested that opiate users have high levels of criminal behaviour prior to onset-opiate use with the level of this predicting escalation post-opiate use onset ([@bib0375]).

Conclusions {#sec0115}
===========

Given the prominence of the drugs-crime link in drug policy, there is a surprising lack of robust evidence focusing specifically on pathways through opiate use and offending. We have established that the evidence base is: (a) out of date and may not apply to the current situation; (b) methodologically very weak. Understanding the temporal nature of the relationship between opiate use and crime is of prime importance to the development of strategies designed to intervene at critical points during the natural history of drug use and offending. We therefore recommend that, if policy continues to be based on the assumed link between opiate use and crime, there is a need for new, methodologically more appropriate research considering the influences on crime. This needs to utilise a longitudinal design with a matched non-opiate user comparison group.

Appendix A. Supplementary data {#sec0135}
==============================
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###### 

Characteristics of 20 included studies.

Table 1

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study        Country   Drug use focus                                   Setting                                    Sample size     Gender                             Age[a](#tblfn0005){ref-type="table-fn"}
  ------------ --------- ------------------------------------------------ ------------------------------------------ --------------- ---------------------------------- -----------------------------------------------
  [@bib0005]   US        Heroin                                           Outpatient methadone treatment             *N* = 101/160   Male 65% of *N* = 160              Mean 24 yrs (*N* = 160)

  [@bib0030]   US        Narcotics (opiates)                              Methadone clinics                          *N* = 503/671   Male 100%                          Mean 20.5 yrs (at addiction)

  [@bib0040]   UK        Heroin                                           Hospital addiction unit                    *N* = 34        Male 100%                          Mean 20 yrs (at addiction)

  [@bib0090]   US        Narcotics (opiates)                              Hospital narcotic treatment facility       *N* = 168       Female 100%                        Mean 34 yrs (at admission)

  [@bib0105]   US        Narcotics (opiates)                              Methadone clinic                           *N* = 210/269   Female 22%                         Mean 33 yrs (at admission)/range 18--77 yrs

  [@bib0145]   UK        Narcotics (heroin)                               Drug clinic                                *N* = 60\       Male 100% of *N* = 60 (baseline)   Mean 22 yrs (SD 3.5 yrs)
                                                                                                                     (at baseline)                                      

  [@bib0200]   UK        Heroin                                           Remand centres & women\'s prison           *N* = 116       Male 43%                           Mean 24 yrs (M): 90% \<30 yrs\
                                                                                                                                                                        Mean 20 yrs (F): range 16--50 yrs

  [@bib0205]   US        Opiates                                          Not reported                               *N* = 134/268   Female 100%                        Mean 25 yrs (*N* = 268)

  [@bib0210]   UK        Heroin                                           Prisons & Drug Dependency Units            *N* = 46        Male 63%                           Mean not reported\
                                                                                                                                                                        91% \< 29 yrs

  [@bib0260]   US        Narcotics (opiates)                              Addict program                             *N* = 452/690   Male 100%                          Mean 25 yrs (at admission)

  [@bib0280]   UK        Opiates                                          Psychiatric Hospitals & General Practice   *N* = 273       Male 76%                           Mean not reported

  [@bib0270]   UK        Opiates                                          Hospital                                   *N* = 74/99     Male 100%                          Mean not reported 56%\
                                                                                                                                                                        14--20 yrs (when notified to Home Office)

  [@bib0275]   UK        Heroin                                           Community                                  *N* = 80        Male 84%                           Mean not reported

  [@bib0285]   US        Narcotics (opiates)                              Community                                  *N* = 252       Male 100%                          Mean not reported

  [@bib0300]   US        Narcotics [b](#tblfn0010){ref-type="table-fn"}   Hospital narcotic treatment facility       *N* = 266       Male 80%                           Mean not reported

  [@bib0315]   UK        Heroin                                           Community                                  *N* = 91/279    Not reported                       Mean "about 21" (total study): 93% 17--32 yrs

  [@bib0420]   US        Heroin                                           Addiction treatment facility               *N* = 765       Not reported                       Mean not reported

  [@bib0425]   US        Opiates                                          Jail                                       *N* = 276/282   Male 81%                           Median 26 yrs

  [@bib0430]   US        Opiates                                          Jail                                       *N* = 200       Male 84%                           Mean 27 yrs/range 19--56 yrs

  [@bib0440]   UK        Opiates                                          Hospital drug dependence clinics           *N* = 236       Male 50%                           Mean not reported
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SD not reported in the majority of studies

presumed opiates based on publications using the same sample source

###### 

Study design features and assessment of study quality.

Table 2

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
               Data collection                                      Nature of data                Observation periods[\*](#tblfn0030){ref-type="table-fn"}   Study quality           
  ------------ ---------------------------------------------------- ----------------------------- ---------------------------------------------------------- --------------- --- --- ---
  [@bib0005]   Retrospective                                        Objective: CR                 Not specified                                              2               1   3   6

  [@bib0030]   Retrospective                                        Objective: CR\                Pre Mean = 4.8 yrs\                                        2               1   3   6
                                                                    Subjective: I                 Post Mean = 14.75 yrs                                                              

  [@bib0040]   Unclear                                              Objective: court records\     Not specified                                              1               0   2   3
                                                                    Subjective: I                                                                                                    

  [@bib0090]   Retrospective                                        Objective: CR\                Pre Mean = 4.1 yrs\                                        2               0   3   5
                                                                    Subjective: I                 Post Mean = 7.8 yrs                                                                

  [@bib0105]   Retrospective                                        Objective: CR                 Pre Mean = 5.5 yrs\                                        3               1   3   7
                                                                                                  Post Mean = 13.3 yrs                                                               

  [@bib0145]   Retrospective[\#](#tblfn0035){ref-type="table-fn"}   Objective: CR\                Pre Mean = 60.5 m\                                         3               1   3   7
                                                                    Subjective: I                 Post not specified                                                                 

  [@bib0200]   Retrospective                                        Objective: CR                 Not specified                                              2               0   3   5

  [@bib0205]   Retrospective                                        Objective: CR\                Pre \> 5 yrs\                                              3               1   3   7
                                                                    Subjective: I                 Post Mean = 1.8 yrs                                                                

  [@bib0210]   Retrospective                                        Objective: CR\                Not specified                                              2               1   2   5
                                                                    Subjective: SR                                                                                                   

  [@bib0260]   Retrospective                                        Objective: CR\                Pre = 12 m\                                                2               1   3   6
                                                                    Subjective: SR                Post = 12 m                                                                        

  [@bib0280]   Retrospective                                        Objective: CR                 Pre Mean = 8.4 yrs\                                        2               0   3   5
                                                                                                  Post Mean = 2.8 yrs                                                                

  [@bib0270]   Retrospective                                        Objective: CR                 Pre not specified\                                         2               0   2   4
                                                                                                  Post =2 yrs                                                                        

  [@bib0275]   Retrospective                                        Objective: CR Subjective: I   Pre not specified\                                         2               0   3   5
                                                                                                  Post = 2--4 yrs                                                                    

  [@bib0285]   Retrospective                                        Objective: CR Subjective: I   Not specified                                              2               1   3   6

  [@bib0300]   Retrospective                                        Objective: CR                 Pre not specified\                                         2               0   3   5
                                                                                                  Post = 2--28 yrs                                                                   

  [@bib0315]   Retrospective                                        Objective: CR                 Pre not specified\                                         3               1   3   7
                                                                                                  Post = 1--9 yrs                                                                    

  [@bib0420]   Retrospective                                        Objective: CR                 Not specified                                              2               0   1   3

  [@bib0425]   Retrospective                                        Objective: CR                 Pre = 1.5--9.6 yrs\                                        2               1   3   6
                                                                                                  Post = 3.3--4.3 yrs                                                                

  [@bib0430]   Retrospective                                        Objective: CR Subjective: I   Pre = 2.3--7.5 yrs\                                        2               1   3   6
                                                                                                  Post = 3.4--5.8 yrs                                                                

  [@bib0440]   Retrospective                                        Objective: CR                 Pre = max 7.1 yrs\                                         2               1   3   6
                                                                                                  Post = max 8.5 yrs                                                                 
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Representativeness, selection, exposure.

Study controls.

Assessment of outcome, length of FU, adequate FU. CR: Criminal Records. I: Interview. SR: self-report.

Estimated from data presented in the paper.

FU reported in other publications by the same author.

###### 

Age at opiate use onset and offending onset.[a](#tblfn0040){ref-type="table-fn"}

Table 3

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study (lead author)\   Mean age at offending onset           Other age/offending data                                                  Mean age at opiate use onset   Other age/drug data
  ---------------------- ------------------------------------- ------------------------------------------------------------------------- ------------------------------ ---------------------------------------------------------------------------
  [@bib0005])            --                                    Takes 17 yrs as the start point for crime classification                  --                             Takes 17 yrs as the start of the pre-addiction period

  [@bib0030]             16.2 yrs/15.2 yrs\                    --                                                                        19.2 yrs/18.6 yrs              Mean age at addiction = 20.7 yrs/20.3 yrs
                         (self-report mean age first arrest)                                                                                                            

  [@bib0040]             --                                    --                                                                        --                             Mean age at addiction = 20 yrs

  [@bib0090]             22.4 yrs/21.2 yrs\                    --                                                                        27.4 yrs/21.3 yrs              --
                         (mean age first arrest)                                                                                                                        

  [@bib0105]             --                                    Takes 15 yrs as the start point for crime classification                  --                             Takes 15 yrs as the start of the pre-addiction period\
                                                                                                                                                                        Mean age at addiction = 20.5 yrs

  [@bib0145]             --                                    --                                                                        --                             --

  [@bib0200]             17.2 yrs\                             --                                                                        --                             50% opiate use onset at 18--19 yrs (F)\
                         (mean age first conviction) (M)                                                                                                                Mean age first drug offence = 22.8 yrs (M)

  [@bib0205]             14.3 yrs/13.7 yrs\                    12.98 yrs/12.22 yrs\                                                      20.1 yrs/18.3 yrs              --
                         (mean age first juvenile arrest)      (self-report mean age first criminal involvement)                                                        

  [@bib0210]             --                                    --                                                                        --                             --

  [@bib0260]             15.1 yrs/14.8 yrs\                    --                                                                        18.6 yrs/19 yrs                Mean age at addiction = 20.4 yrs/20.9 yrs
                         (mean age first arrest)                                                                                                                        

  [@bib0280]             --                                    Age first conviction: 8--14 yrs (15%)/14--17 yrs (20%)/17--21 yrs (25%)   --                             19.6 yrs = median age at start of "early opiate use"

  [@bib0270]             --                                    --                                                                        --                             --

  [@bib0275]             --                                    Males convicted \<21 yrs (35%)\                                           16.6 yrs/17 yrs                --
                                                               Females court appearance \<17 yrs (38.5%)                                                                

  [@bib0285]             --                                    --                                                                        --                             Takes 14 yrs as the start of the pre- opiate use period

  [@bib0300]             --                                    --                                                                        --                             Median age at addiction=\
                                                                                                                                                                        31.3 yrs (M) 30 yrs (F)

  [@bib0315]             --                                    Analysed data by age at onset offending \<16 yrs vs. \>16 yrs             --                             Assumes age of onset = 16 yrs (from previous work: [@bib0310])

  [@bib0420]             --                                    --                                                                        --                             Mean age at addiction = 21 yrs

  [@bib0425]             --                                    --                                                                        --                             Majority (39%) 13--20 yrs (assumes age at first drug arrest as onset age)

  [@bib0430]             --                                    --                                                                        --                             41% 18--21 yrs at addiction (daily use)

  [@bib0440]             --                                    Males convicted \< 17.3 yrs (32%)\                                        --                             --
                                                               Females convicted \< 16.7 yrs (12%)                                                                      

  *Mean (95% CI)*        *16.7* yrs *(14.3--19.0)*                                                                                       19.6 yrs (17.4--21.8)          
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

None of the before/after studies reported a within-client SD for delay (opiate use onset-CJS onset).

###### 

Total recorded offending.

Table 4

                                                                                      Pre-opiate use offending rate   Post-opiate use offending rate   Rate ratio   95% CI[a](#tblfn0045){ref-type="table-fn"}
  ----------------------------------------------------------------------------------- ------------------------------- -------------------------------- ------------ --------------------------------------------
  *Conviction rates*                                                                                                                                                
  [@bib0005] (*n* = 101)                                                              0.28                            0.2                              0.71         0.40--1.3
  [@bib0210] (*n* = 46)                                                               1.0                             2.2                              2.2          1.5--3.1
  [@bib0280] (male group: *n* = 207)                                                  0.46                            0.63                             1.4          1.1--1.7
  [@bib0315] (*n* = 91)[d](#tblfn0060){ref-type="table-fn"}                           0.26                            1.2                              4.6          3.8--5.6
  [@bib0315] (*n* = 91)[e](#tblfn0065){ref-type="table-fn"}                           0.22                            0.42                             1.9          1.5--2.4
  [@bib0440]^h^ (all: *n* = 236)[f](#tblfn0070){ref-type="table-fn"}                  0.08                            0.50                             6.2          5.3--7.3
  [@bib0440]^h^ (all: *n* = 236)[g](#tblfn0075){ref-type="table-fn"}                  0.08                            0.38                             4.7          4.0--5.6
  [@bib0440]^h^ (male group: *n* = 119)[f](#tblfn0070){ref-type="table-fn"}           0.12                            0.64                             5.3          4.4--6.5
  [@bib0440]^h^ (male group: *n* = 119)[g](#tblfn0075){ref-type="table-fn"}           0.12                            0.48                             4.0          3.3--4.9
  [@bib0440]^h^ (female group: *n* = 117)[f](#tblfn0070){ref-type="table-fn"}         0.04                            0.35                             8.7          6.6--11.7
  [@bib0440]^h^ (female group: *n* = 117)[g](#tblfn0075){ref-type="table-fn"}         0.04                            0.27                             6.7          5.0--9.1
                                                                                                                                                                    
  *Arrest rates*                                                                                                                                                    
  [@bib0005] (*n* = 101)                                                              0.55                            0.42                             0.76         0.51--1.1
  [@bib0030] (White group: *n* = 275)                                                 0.81                            1.2                              1.5          1.3--1.8
  [@bib0030] (Mexican American group: *n* = 228)                                      0.99                            1.4                              1.4          1.2--1.7
  [@bib0105] (*n* = 210)                                                              0.03                            0.35                             11.3         9.0--14.3
  [@bib0260] (1962--64 group: *n* = 277)                                              1.4                             1.9                              1.4          1.2--1.6
  [@bib0260] (1970 group: *n* = 175)                                                  1.7                             2.7                              1.6          1.4--1.8
  [@bib0425] (Black group: *n* = 113)[c](#tblfn0055){ref-type="table-fn"}             1.2                             1.6                              1.3          1.0--1.6
  [@bib0425] (Hispanic group: *n* = 86)[c](#tblfn0055){ref-type="table-fn"}           1.6                             1.6                              1.0          0.79--1.3
  [@bib0425] (White group: *n* = 77)[c](#tblfn0055){ref-type="table-fn"}              1.3                             1.5                              1.1          0.88--1.5
  [@bib0425] (male group: *n* = 223)[c](#tblfn0055){ref-type="table-fn"}              1.4                             1.7                              1.2          1.0--1.4
  [@bib0425] (female group: *n* = 53)[c](#tblfn0055){ref-type="table-fn"}             1.3                             2.1                              1.6          1.2--2.1
  [@bib0425] (13--20 onset group: *n* = 109)[c](#tblfn0055){ref-type="table-fn"}      1.7                             1.4                              0.80         0.64--0.99
  [@bib0425] (21--25 onset group: *n* = 99)[c](#tblfn0055){ref-type="table-fn"}       1.2                             2.6                              2.1          1.7--2.7
  [@bib0425] (26+ onset group: *n* = 68)[c](#tblfn0055){ref-type="table-fn"}          1.1                             1.2                              1.1          0.82--1.5
  [@bib0430] (Black group: *n* = 73)[b](#tblfn0050){ref-type="table-fn"}              0.56                            2.8                              4.9          3.5--6.9
  [@bib0430] (Black group: *n* = 73)[c](#tblfn0055){ref-type="table-fn"}              0.53                            1.2                              2.3          1.6--3.4
  [@bib0430] (Mexican American group: *n* = 81)[b](#tblfn0050){ref-type="table-fn"}   0.46                            2.3                              5.0          3.5--7.1
  [@bib0430] (Mexican American group: *n* = 81)[c](#tblfn0055){ref-type="table-fn"}   0.40                            0.93                             2.3          1.5--3.5
  [@bib0430] (White group: *n* = 46)[b](#tblfn0050){ref-type="table-fn"}              0.23                            1.7                              7.6          4.0--14.4
  [@bib0430] (White group *n* = 46)[c](#tblfn0055){ref-type="table-fn"}               0.22                            0.91                             4.1          2.1--8.2
  [@bib0430] (male group: *n* = 167)[b](#tblfn0050){ref-type="table-fn"}              0.49                            2.4                              4.9          3.9--6.2
  [@bib0430] (male group: *n* = 167)[c](#tblfn0055){ref-type="table-fn"}              0.45                            1.1                              2.4          1.8--3.1
  [@bib0430] (female group: *n* = 33)[b](#tblfn0050){ref-type="table-fn"}             0.18                            2.1                              11.4         4.9--26.5
  [@bib0430] (female group: *n* = 33)[c](#tblfn0055){ref-type="table-fn"}             0.17                            0.97                             5.7          2.3--14.0
  [@bib0430] (13--17 onset group: *n* = 51)[b](#tblfn0050){ref-type="table-fn"}       0.07                            1.8                              25.7         8.9--74.0
  [@bib0430] (13--17 onset group: *n* = 51)[c](#tblfn0055){ref-type="table-fn"}       0.07                            0.94                             13.4         4.6--39.4
  [@bib0430] (18--21 onset group: *n* = 83)[b](#tblfn0050){ref-type="table-fn"}       0.57                            2.4                              4.2          3.1--5.8
  [@bib0430] (18--21 onset group: *n* = 83)[c](#tblfn0055){ref-type="table-fn"}       0.54                            1.1                              2.1          1.4--2.9
  [@bib0430] (22+ onset group: *n* = 66)[b](#tblfn0050){ref-type="table-fn"}          0.54                            2.7                              5.0          3.5--7.2
  [@bib0430] (22+ onset group: *n* = 66) [c](#tblfn0055){ref-type="table-fn"}         0.48                            1.1                              2.2          1.4--3.4

Calculated using estimated number of events if not reported, mean SE where missing.

Total reported crime.

Total non-drug reported crime.

Total acquisitive crime (burglary, theft).

Total non-acquisitive crime.

Total convictions.

Total non-drug offence convictions.

###### 

Recorded crime categories.

Table 5

                                                                                      Pre-opiate use offending rate   Post-opiate use offending rate   Rate ratio   95% CI[a](#tblfn0080){ref-type="table-fn"}
  ----------------------------------------------------------------------------------- ------------------------------- -------------------------------- ------------ --------------------------------------------
  *Theft*                                                                                                                                                           
  [@bib0005] (*n* = 101)                                                              0.09                            0.06                             0.67         0.24--1.9
  [@bib0030] (White group: *n* = 275)                                                 0.03                            0.11                             3.7          1.7--7.9
  [@bib0030] (Mexican American group: *n* = 228)                                      0.04                            0.10                             2.5          1.2--5.4
  [@bib0105] (*n* = 210)[b](#tblfn0085){ref-type="table-fn"}                          0.01                            0.11                             8.3          6.6--10.5
  [@bib0260] (1962--64 group: *n* = 277)[c](#tblfn0090){ref-type="table-fn"}          0.05                            0.10                             2.0          1.0--3.8
  [@bib0260] (1970 group: *n* = 175)[c](#tblfn0090){ref-type="table-fn"}              0.12                            0.23                             1.9          1.1--3.2
  [@bib0280] (male group: *n* = 207)                                                  0.15                            0.14                             0.95         0.58--1.5
  [@bib0425] (Black group: *n* = 113)                                                 0.47                            0.55                             1.1          0.80--1.7
  [@bib0425] (Hispanic group: *n* = 86)                                               0.41                            0.58                             1.4          0.92--2.2
  [@bib0425] (White group: *n* = 77)                                                  0.50                            0.31                             0.63         0.38--1.0
  [@bib0425] (male group: *n* = 223)                                                  0.43                            0.50                             1.2          0.88--1.5
  [@bib0425] (female group: *n* = 53)                                                 0.59                            0.86                             1.5          0.93--2.3
  [@bib0425] (13--20 onset group: *n* = 109)                                          0.52                            0.49                             0.95         0.65--1.4
  [@bib0425] (21--25 onset group: *n* = 99)                                           0.41                            0.75                             1.8          1.2--2.7
  [@bib0425] (26+ onset group: *n* = 68)                                              0.44                            0.41                             0.94         0.56--1.6
  [@bib0430] (Black group: *n* = 73)                                                  0.20                            0.50                             2.5          1.4--4.6
  [@bib0430] (Mexican American group: *n* = 81)                                       0.11                            0.27                             2.4          1.1--5.3
  [@bib0430] (White group: *n* = 46)                                                  0.08                            0.25                             3.1          0.97--10.1
  [@bib0430] (male group: *n* = 167)                                                  0.15                            0.35                             2.3          1.5--3.7
  [@bib0430] (female group: *n* = 33)                                                 0.05                            0.35                             7.0          1.4--35.7
  [@bib0430] (13--17 onset group: *n* = 51)                                           0.05                            0.35                             7.0          1.9--26.0
  [@bib0430] (18--21 onset group: *n* = 83)                                           0.19                            0.35                             1.8          1.0--3.4
  [@bib0430] (22+ onset group: *n* = 66)                                              0.14                            0.36                             2.6          1.2--5.5
                                                                                                                                                                    
  *Burglary*                                                                                                                                                        
  [@bib0005] (*n* = 101)[d](#tblfn0095){ref-type="table-fn"}                          0.09                            0.10                             1.1          0.45--2.7
  [@bib0030] (White group: *n* = 275)                                                 0.08                            0.20                             2.5          1.5--4.1
  [@bib0030] (Mexican American group: *n* = 228)                                      0.16                            0.19                             1.2          0.76--1.8
  [@bib0105] (*n* = 210)[e](#tblfn0100){ref-type="table-fn"}                          0.01                            0.09                             9.7          7.7--12.2
  [@bib0260] (1962--64 group: *n* = 277)                                              0.16                            0.25                             1.6          0.60--4.1
  [@bib0260] (1970 group: *n* = 175)                                                  0.23                            0.46                             2.0          1.4--2.9
  [@bib0280] (male group: *n* = 207)[g](#tblfn0110){ref-type="table-fn"}              0.09                            0.07                             0.79         0.40--1.5
  [@bib0425] (Black group: *n* = 113)                                                 0.12                            0.47                             4.0          2.2--7.3
  [@bib0425] (Hispanic group: *n* = 86)                                               0.32                            0.26                             0.83         0.48--1.4
  [@bib0425] (White group: *n* = 77)                                                  0.23                            0.24                             1.0          0.54--2.0
  [@bib0425] (male group: *n* = 223)                                                  0.25                            0.46                             1.8          1.3--2.5
  [@bib0425] (female group: *n* = 53)                                                 0.03                            0.08                             2.8          0.45--17.0
  [@bib0425] (13--20 onset group: *n* = 109)                                          0.34                            0.26                             0.74         0.45--1.2
  [@bib0425] (21--25 onset group: *n* = 99)                                           0.12                            0.59                             4.8          2.6--8.9
  [@bib0425] (26+ onset group: *n* = 68)                                              0.13                            0.30                             2.3          1.1--5.0
  [@bib0430] (Black group: *n* = 73)                                                  0.10                            0.18                             1.8          0.73--4.4
  [@bib0430] (Mexican American group: *n* = 81)                                       0.13                            0.24                             1.8          0.9--3.9
  [@bib0430] (White group: *n* = 46)                                                  0.03                            0.20                             6.7          1.1--39.9
  [@bib0430] (male group: *n* = 167)                                                  0.11                            0.23                             2.1          1.2--3.6
  [@bib0430] (female group: *n* = 33)                                                 0.002                           0.10                             50.0         0.02--110727.0
  [@bib0430] (13--17 onset group: *n* = 51)                                           0.00                            0.23                             --           --
  [@bib0430] (18--21 onset group: *n* = 83)                                           0.14                            0.21                             1.5          0.71--3.1
  [@bib0430] (22+ onset group: *n* = 66)                                              0.12                            0.18                             1.5          0.61--3.7
                                                                                                                                                                    
  *Violence*                                                                                                                                                        
  [@bib0005] (*n* = 101)                                                              0.03                            0.04                             1.3          0.30--5.9
  [@bib0030] (White group: *n* = 275)                                                 0.02                            0.04                             2.0          0.72--5.6
  [@bib0030] (Mexican American group: *n* = 228)                                      0.09                            0.05                             0.56         0.27--1.1
  [@bib0105] (*n* = 210)                                                              0.003                           0.02                             6.7          5.3--8.4
  [@bib0260] (1962--64 group: *n* = 277)                                              0.03                            0.03                             1.0          0.38--2.6
  [@bib0260] (1970 group: *n* = 175)                                                  0.03                            0.05                             1.7          0.65--4.3
  [@bib0280] (male group: *n* = 207)                                                  0.04                            0.04                             1.03         0.41--2.6
  [@bib0425] (Black group: *n* = 113)[f](#tblfn0105){ref-type="table-fn"}             0.11                            0.08                             0.68         0.29--1.6
  [@bib0425] (Hispanic group: *n* = 86)[f](#tblfn0105){ref-type="table-fn"}           0.09                            0.19                             2.1          0.90--4.9
  [@bib0425] (White group: *n* = 77)[f](#tblfn0105){ref-type="table-fn"}              0.05                            0.33                             6.1          2.2--17.3
  [@bib0425] (male group: *n* = 223)[f](#tblfn0105){ref-type="table-fn"}              0.10                            0.11                             1.1          0.61--1.9
  [@bib0425] (female group: *n* = 53)[f](#tblfn0105){ref-type="table-fn"}             0.03                            0.50                             16.0         3.3--77.4
  [@bib0425] (13--20 onset group: *n* = 109)[f](#tblfn0105){ref-type="table-fn"}      0.10                            0.19                             2.0          0.94--4.1
  [@bib0425] (21--25 onset group: *n* = 99)[f](#tblfn0105){ref-type="table-fn"}       0.06                            0.27                             4.6          1.9--11.4
  [@bib0425] (26+ onset group: *n* = 68)[f](#tblfn0105){ref-type="table-fn"}          0.12                            0.05                             0.39         0.11--1.4
  [@bib0430] (Black group: *n* = 73)[f](#tblfn0105){ref-type="table-fn"}              0.05                            0.17                             3.4          1.1--10.9
  [@bib0430] (Mexican American group: *n* = 81)[f](#tblfn0105){ref-type="table-fn"}   0.06                            0.08                             1.3          0.47--3.8
  [@bib0430] (White group: *n* = 46)[f](#tblfn0105){ref-type="table-fn"}              0.00                            0.08                             --           --
  [@bib0430] (male group: *n* = 167)[f](#tblfn0105){ref-type="table-fn"}              0.05                            0.14                             2.8          1.3--6.2
  [@bib0430] (female group: *n* = 33)[f](#tblfn0105){ref-type="table-fn"}             0.01                            0.02                             2.0          0.03--130.0
  [@bib0430] (13--17 onset group: *n* = 51)[f](#tblfn0105){ref-type="table-fn"}       0.00                            0.10                             --           --
  [@bib0430] (18--21 onset group: *n* = 83)[f](#tblfn0105){ref-type="table-fn"}       0.08                            0.15                             1.9          0.73--4.8
  [@bib0430] (22+ onset group: *n* = 66)[f](#tblfn0105){ref-type="table-fn"}          0.04                            0.10                             2.5          0.60--10.4
                                                                                                                                                                    
  *Robbery*                                                                                                                                                         
  [@bib0030] (White group: *n* = 275)                                                 0.02                            0.03                             1.5          0.51--4.4
  [@bib0030] (Mexican American group: *n* = 228)                                      0.04                            0.03                             0.88         0.28--2.0
  [@bib0105] (*n* = 210)                                                              0.01                            0.03                             4.6          3.7--5.9
  [@bib0260] (1962--64 group: *n* = 277)                                              0.04                            0.02                             0.50         0.18--1.4
  [@bib0260] (1970 group: *n* = 175)                                                  0.02                            0.10                             5.0          1.6--15.8
  [@bib0425] (Black group: *n* = 113)                                                 0.09                            0.15                             1.6          0.73--3.4
  [@bib0425] (Hispanic group: *n* = 86)                                               0.08                            0.09                             1.2          0.43--3.4
  [@bib0425] (White group: *n* = 77)                                                  0.06                            0.25                             4.5          1.6--12.7
  [@bib0425] (male group: *n* = 223)                                                  0.09                            0.19                             2.2          1.3--3.8
  [@bib0425] (female group: *n* = 53)                                                 0.05                            0.03                             0.56         0.08--4.0
  [@bib0425] (13--20 onset group: *n* = 109)                                          0.10                            0.09                             0.93         0.39--2.2
  [@bib0425] (21--25 onset group: *n* = 99)                                           0.07                            0.26                             3.6          1.6--8.3
  [@bib0425] (26+ onset group: *n* = 68)                                              0.06                            0.12                             2.1          0.61--7.0
  [@bib0430] (Black group: *n* = 73)                                                  0.06                            0.08                             1.3          0.39--4.6
  [@bib0430] (Mexican American group: *n* = 81)                                       0.02                            0.08                             4.0          0.72--22.4
  [@bib0430] (White group: *n* = 46)                                                  0.05                            0.10                             2.0          0.41--9.8
  [@bib0430] (male group: *n* = 167)                                                  0.04                            0.09                             2.2          0.90--5.6
  [@bib0430] (female group: *n* = 33)                                                 0.07                            0.04                             0.57         0.07--4.8
  [@bib0430] (13--17 onset group: *n* = 51)                                           0.00                            0.12                             --           --
  [@bib0430] (18--21 onset group: *n* = 83)                                           0.05                            0.07                             1.4          0.40--4.9
  [@bib0430] (22+ onset group: *n* = 66)                                              0.06                            0.07                             1.2          0.30--4.5
                                                                                                                                                                    
  *Prostitution*                                                                                                                                                    
  [@bib0105] (*n* = 210)                                                              0.001                           0.03                             33.0         26.2--41.6
  [@bib0425] (male group: *n* = 223)                                                  0.001                           0.003                            3.0          0.02--365.3
  [@bib0425] (female group: *n* = 53)                                                 0.40                            0.27                             0.69         0.35--1.3
  [@bib0430](Black group: *n* = 73)                                                   0.001                           0.11                             110.0        0.08--160774.9
  [@bib0430] (Mexican American group: *n* = 81)                                       0.00                            0.02                             --           --
  [@bib0430] (White group: *n* = 46)                                                  0.00                            0.02                             --           --
  [@bib0430] (male group: *n* = 167)                                                  0.00                            0.02                             --           --
  [@bib0430] (female group: *n* = 33)                                                 0.00                            0.23                             --           --
  [@bib0430] (13--17 onset group: *n* = 51)                                           0.00                            0.02                             --           --
  [@bib0430] (18--21 onset group: *n* = 83)                                           0.00                            0.08                             --           --
  [@bib0430] (22+ onset group: *n* = 66)                                              0.001                           0.05                             50.0         0.02--110727.0

Calculated using estimated number of events if not reported.

'money' crime.

Petty theft/forgery.

Property felony.

Crime against property.

Assault.

'breaking and entering'.
